Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Acta Anaesthesiol Scand ; 49(8): 1142-8, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16095456

RESUMO

BACKGROUND: Anti-inflammatory action of Antithrombin III (AT III) is still not well understood in ischemia/reperfusion (I/R) injury. In the present study, we aimed to investigate the anti-inflammatory action of AT III on remote lung and local skeletal muscle tissue injury in a rat model of bilateral lower limb I/R model. METHODS: Bilateral lower limb ischemia and reperfusion were produced by means of tourniquets occlusions and releases, respectively. Three groups of rats were used in this controlled study: sham group (sham, n=3) underwent 5 h of anesthesia only; control group (I/R, n=7) underwent 3 h of bilateral lower limb ischemia followed by 2 h of reperfusion; and AT III pretreated group (I/R-AT III, n=6) underwent the same procedure as the control group, but also received i.v. 250 U kg-1 AT III 30 min before ischemia induction under midazolam and fentanyl anesthesia. MEASUREMENTS AND RESULTS: Lung and muscle tissue accumulation of polymorphonuclear leukocytes (PMN) were assessed by measuring tissue myeloperoxidase (MPO) activity. Histopathological changes in tissues were assessed by PMN counts in the lung, and muscle tissues and by histological lung injury score. Plasma 6-keto prostaglandin F(1alpha) and tumor necrosis factor alpha levels were measured by an enzyme immunoassay technique. Myeloperoxidase activity could not be detected in the muscle tissues of all groups. The lung and muscle tissue PMN counts in the I/R group were significantly higher compared with the I/R-AT III group (P<0.05). CONCLUSIONS: Data from the present study provides some evidence that AT III pretreatment attenuates remote lung and local skeletal muscle tissue injury caused by lower limb I/R.


Assuntos
Antitrombina III/farmacologia , Isquemia/fisiopatologia , Extremidade Inferior/irrigação sanguínea , Pulmão/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Infiltração de Neutrófilos/efeitos dos fármacos , 6-Cetoprostaglandina F1 alfa/sangue , Animais , Anticoagulantes/farmacologia , Modelos Animais de Doenças , Isquemia/tratamento farmacológico , Isquemia/imunologia , Precondicionamento Isquêmico/métodos , Pulmão/metabolismo , Músculo Esquelético/metabolismo , Neutrófilos/efeitos dos fármacos , Peroxidase/efeitos dos fármacos , Projetos Piloto , Ratos , Ratos Wistar , Reperfusão , Traumatismo por Reperfusão/prevenção & controle , Fator de Necrose Tumoral alfa/efeitos dos fármacos
2.
J Int Med Res ; 31(5): 428-33, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14587312

RESUMO

Interscalene brachial plexus block (ISB) anaesthesia is widely used with or without general anaesthesia in patients undergoing shoulder surgery, which is generally done with the patient in a sitting position. This position affects haemodynamics, and supplementing ISB with general anaesthesia can exaggerate these haemodynamic changes. This study compared ISB combined with general anaesthesia, with ISB alone, in 29 patients undergoing elective shoulder surgery. Heart rate and oxygen saturation remained stable throughout the study in both groups. Mean arterial pressure was significantly decreased when the patient moved into the sitting position in those given combined anaesthesia, whereas in those given ISB alone mean arterial pressure did not change significantly. Neither pain scores nor patient satisfaction scores differed significantly between the two groups. All of the patients were either satisfied or entirely satisfied with their anaesthesia/analgesia. There were no significant differences in side-effects and no severe complications in either group. We advocate using ISB alone for patients undergoing shoulder surgery, but further larger studies are needed to confirm the present results.


Assuntos
Anestesia Geral/métodos , Plexo Braquial/patologia , Bloqueio Nervoso/métodos , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Procedimentos Ortopédicos , Oxigênio/metabolismo , Dor Pós-Operatória , Pressão , Ombro , Fatores de Tempo
3.
J Int Med Res ; 31(4): 267-71, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12964501

RESUMO

We compared the antiemetic efficacy of tropisetron versus droperidol in women given tramadol after total hysterectomy. Forty patients were randomly allocated to group 1 (n = 20, tropisetron 0.05 mg/kg intravenously) or group 2 (n = 20, droperidol 15 micrograms/kg intravenously). Tramadol infusion (intravenously), for post-operative analgesia, was started at fascia closure. Incidences of post-operative nausea and vomiting, pain intensity, tramadol use, and the need for a rescue antiemetic (metoclopramide 10 mg) were recorded 0 h, 2 h, 6 h, 12 h, 24 h and 48 h post-operatively. Vomiting and nausea incidences were reported fewer in group 1 than in group 2, but statistical significance was only reached for vomiting incidence 6 h post-operation. Tropisetron seems to have better antiemetic properties than droperidol in patients receiving tramadol because of the length of its duration of action. Further studies, investigating alternative ways of managing post-operative nausea and vomiting, and the use of tramadol for post-operative analgesia, are needed.


Assuntos
Antieméticos/uso terapêutico , Droperidol/uso terapêutico , Indóis/uso terapêutico , Entorpecentes/uso terapêutico , Náusea e Vômito Pós-Operatórios/tratamento farmacológico , Tramadol/uso terapêutico , Vômito/tratamento farmacológico , Adolescente , Adulto , Idoso , Feminino , Humanos , Histerectomia , Pessoa de Meia-Idade , Entorpecentes/administração & dosagem , Autoadministração , Tramadol/administração & dosagem , Tropizetrona
5.
J Int Med Res ; 30(3): 318-21, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12166350

RESUMO

We investigated the effect of midazolam pre-medication on rocuronium-induced neuromuscular blockade during sevoflurane anaesthesia. Twenty-two patients scheduled for elective surgery were randomly divided to receive either no pre-medication (control group) or pre-medication with 0.1 mg/kg midazolam intramuscularly (midazolam group). Anaesthesia was induced with fentanyl and propofol, and maintained with sevoflurane and nitrous oxide in oxygen. Neuromuscular responses were monitored using acceleromyography. The onset and clinical duration of action, time to recovery of first twitch of train-of-four (TOF) response to 75% of control, recovery index and time for TOF recovery to 25% and 50% were recorded. Patient-related data were similar in both groups. The parameters recorded were not significantly different between the groups. Midazolam pre-medication does not influence the time-course of action of rocuronium during sevoflurane anaesthesia.


Assuntos
Adjuvantes Anestésicos/uso terapêutico , Androstanóis/uso terapêutico , Midazolam/uso terapêutico , Fármacos Neuromusculares não Despolarizantes/uso terapêutico , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Rocurônio
6.
Pathol Oncol Res ; 7(3): 209-12, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11692148

RESUMO

Cellular proliferation programmed cell death (apoptosis) are associated with tumor growth in general, and prostate cancer growth in particular. The aim of this study was to examine the expression of the apoptosis regulating genes bcl-2 and p53 and Gleason score in core needle biopsy specimens of prostate cancer using immunohistochemistry. We studied bcl-2 and p53 expression in 12 cases of low grade (Gleason score 2-5), 12 cases of intermediate grade (Gleason score 6-7) and 8 cases of high grade (Gleason score 8-10) prostate cancer. Overexpression of bcl-2 was noted in 3 of 32 patients (9.32%). One of them was high grade; others were intermediate grades. Expression of p53 was observed in 3 of low grades; others were high grade. The statistical analysis of present data suggest that there is no significant relation between p53 and bcl-2 expression and Gleason score in prostate cancer.


Assuntos
Adenocarcinoma/metabolismo , Apoptose , Neoplasias da Próstata/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteína Supressora de Tumor p53/metabolismo , Adenocarcinoma/patologia , Idoso , Idoso de 80 Anos ou mais , Progressão da Doença , Humanos , Técnicas Imunoenzimáticas , Masculino , Pessoa de Meia-Idade , Proteínas de Neoplasias/metabolismo , Estadiamento de Neoplasias , Prognóstico , Neoplasias da Próstata/patologia , Estudos Retrospectivos
7.
Int J Gynecol Pathol ; 19(4): 374-6, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11109168

RESUMO

We report a case of 44-year-old woman with persistent pruritic papules on the left and right labium majus of the vulva. Histopathologic examination of the vulvar biopsy specimen revealed a suprabasal separation of the epidermis with acantholysis and dyskeratosis.


Assuntos
Acantólise/patologia , Dermatopatias/patologia , Doenças da Vulva/patologia , Acantólise/imunologia , Adulto , Biópsia , Feminino , Humanos , Imunoglobulina A/análise , Imunoglobulina G/análise , Imunoglobulina M/análise , Imuno-Histoquímica , Dermatopatias/imunologia , Doenças da Vulva/imunologia
8.
Gen Pharmacol ; 35(2): 65-70, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11707311

RESUMO

The aim of the present study was to compare the effects of propofol on cardiac contractile force in normal and hypercholesterolemic isolated rabbit hearts. While one group was fed with standard chow pellets (150 g/day), the other group received cholesterol (1% w/w) in addition to the same amount of rabbit chow pellets during 1 month. Hearts from standard-fed rabbits were given intralipid solvent or 25, 50 and 100 microM propofol by infusion. Hypercholesterolemic rabbit hearts were administered 25, 50 and 100 microM propofol by infusion. All concentrations of propofol did not result in any significant change of the heart rates (HR) in two groups. Propofol (25, 50 and 100 microM) infusion induced a concentration- and time-dependent inhibition in left ventricular pressure (LVP) in standard chow diet group (P<.05,.05 and.05, respectively). In hypercholesterolemic rabbit hearts, 25 and 50 microM propofol infusion developed a significant inhibition in LVP when compared with the standard chow diet group (P<.05 and.05, respectively). Propofol (100 microM) infusion developed a significant increase in LVP after 20 min in hypercholesterolemic rabbit hearts when compared with normal rabbit hearts (P<.05). Supratherapeutic concentration of propofol might have cardioprotective effect on hypercholesterolemic rabbit hearts.


Assuntos
Anestésicos Intravenosos/farmacologia , Coração/efeitos dos fármacos , Hipercolesterolemia/fisiopatologia , Propofol/farmacologia , Animais , Cálcio/metabolismo , Frequência Cardíaca/efeitos dos fármacos , Técnicas In Vitro , Masculino , Contração Miocárdica/efeitos dos fármacos , Coelhos , Função Ventricular Esquerda/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...